Moolec Science S.A. (MLEC) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en Luxembourg, Luxembourg. El CEO actual es Alejandro Antalich.
MLEC tiene fecha de IPO 2021-03-02, 52 empleados a tiempo completo, cotiza en el NASDAQ Global Market, una capitalización de mercado de $5.38M.
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
